Post by tomsylver on Apr 25, 2017 20:24:32 GMT
2017 ASCO ANNUAL MEETING INVESTOR BRIEFING
TESARO will host an investor briefing in connection with the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. This event will be held on Saturday, June 3, at the W Chicago Lakeshore Hotel, Altitude Room, 33rd Floor.
TESARO INVESTOR BRIEFING
W CHICAGO LAKESHORE HOTEL
ALTITUDE ROOM – 33rd FLOOR
644 LAKE SHORE DRIVE
CHICAGO, IL 60611
SATURDAY, JUNE 3, 2017
6:00 RECEPTION
6:15 PRESENTATION WEBCAST AND Q&A
LIVE & ARCHIVED WEBCAST WILL BE AVAILABLE AT WWW.TESAROBIO.COM
During the event, TESARO management will provide a business overview and pipeline update, and will answer questions from investors and analysts. This meeting will be webcast live and archived at www.tesarobio.com.
This event is intended for institutional investors and sell side analysts only. Please RSVP in order to attend. All interested parties are invited to listen to the webcast.
Please contact Jennifer Davis, Vice President, Corporate Affairs & Investor Relations at (781) 325-1116 or jdavis@tesarobio.com to RSVP or with any questions.
TESARO will host an investor briefing in connection with the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. This event will be held on Saturday, June 3, at the W Chicago Lakeshore Hotel, Altitude Room, 33rd Floor.
TESARO INVESTOR BRIEFING
W CHICAGO LAKESHORE HOTEL
ALTITUDE ROOM – 33rd FLOOR
644 LAKE SHORE DRIVE
CHICAGO, IL 60611
SATURDAY, JUNE 3, 2017
6:00 RECEPTION
6:15 PRESENTATION WEBCAST AND Q&A
LIVE & ARCHIVED WEBCAST WILL BE AVAILABLE AT WWW.TESAROBIO.COM
During the event, TESARO management will provide a business overview and pipeline update, and will answer questions from investors and analysts. This meeting will be webcast live and archived at www.tesarobio.com.
This event is intended for institutional investors and sell side analysts only. Please RSVP in order to attend. All interested parties are invited to listen to the webcast.
Please contact Jennifer Davis, Vice President, Corporate Affairs & Investor Relations at (781) 325-1116 or jdavis@tesarobio.com to RSVP or with any questions.